InvestorsHub Logo
icon url

CherryTree1

01/15/17 3:24 PM

#95841 RE: BigBioBoom #95832

I looked on facebook and Kat is not part of the phase-3. I pasted some of the text below. It looks like this experimental treatment can be purchased in Britain I am guessing since they say then need £90,000.

DCVAX - An experimental bespoke vaccine.
To create this surgeons will remove as much of the tumour as possible.

The tissue is kept alive as it is transported to America, there they create the bespoke vaccine which is engineered to attack the very cells is has been created from. A fully personalised vaccine to attack cancer.

This treatment could be revolutionary and lifesaving for many, but it’s not cheap and we desperately need your help.
We need to raise £90,000 to pay for #KatsCure.

You can help, your donations will fund DCVAX treatment and also Avastin, an agent added in to traditional chemotherapy treatments.
Your donation is entrusted in to the hands of UK registered charity, The Brains trust. They will manage your donation to pay for the above treatments.

icon url

biosectinvestor

01/15/17 5:28 PM

#95874 RE: BigBioBoom #95832

I was invested in a company that restored people's eyesight. Phase I didn't have a placebo group because they really never do, but shorts complained in publications as did rival doctors, that you could not know if it was effective without the placebo trial, and so there was a lot of attacking the company, wrongly, for not having a placebo group in Phase I. It was utter nonsense.

They did have a placebo group in their Phase II trial.

However, I always found it quite absurd that a patient could restore tissue that no longer existed, based upon the placebo effect, and see, do eye tests and ride horses, by way of wishful thinking. Unfortunately, that company was so swamped with shorts, including acquirers... that it got bought out cheap. The typical shorts, including AF, said that the complaints of shareholders on the active shorting down into the buyout were just nonsense. I believe such people are a part of a much larger problem in biotech.

Looking forward to their being exposed.